Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 27;12(6):e8863.
doi: 10.7759/cureus.8863.

Esophageal Adenocarcinoma in the Proximal Esophageal Segment: A Unique Presentation in a Male With Alcohol Abuse

Affiliations
Case Reports

Esophageal Adenocarcinoma in the Proximal Esophageal Segment: A Unique Presentation in a Male With Alcohol Abuse

Brandon S Shiflett et al. Cureus. .

Abstract

Esophageal adenocarcinoma (EAC) is a malignancy classically seen in the distal esophagus. While many risk factors associated with the condition have been reported, the most common among them are gastroesophageal reflux disease (GERD) and obesity. Histological changes range from metaplasia within the esophagus from stratified squamous epithelium to non-ciliated columnar cells with goblet cells. In contrast, squamous cell carcinoma (SCC) is classically found in the proximal portion of the esophagus and its risk factors include tobacco and alcohol use. We present a unique case of a 59-year-old African American male who presented to the ED with dysphagia, weight loss, and multiple episodes of emesis. Notable medical history included tobacco abuse, alcohol abuse, and alcoholic cirrhosis. Currently, there are numerous case reports delineating unique presentations of esophageal cancers; however, there are few case reports that demonstrate EAC affecting the proximal segment of the esophagus.

Keywords: esophageal adenocarcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. EGD findings
A: mass on initial EGD; B: continuation of mass on initial EGD; C: PEG placement; D: mass on first readmission EGD; E: mass on second readmission EGD with impaction; F: histology of initial biopsy EGD: esophagogastroduodenoscopy; PEG: percutaneous endoscopic gastrostomy

Similar articles

Cited by

References

    1. Barrett's oesophagus: evidence from the current meta-analyses. Gatenby P, Soon Y. World J Gastrointest Pathophysiol. 2014;5:178–187. - PMC - PubMed
    1. Barrett's esophagus: a comprehensive and contemporary review for pathologists. Naini BV, Souza RF, Odze RD. Am J Surg Pathol. 2016;40:0–66. - PMC - PubMed
    1. Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Rubenstein JH, Shaheen NJ. Gastroenterology. 2015;149:302–317. - PMC - PubMed
    1. Epidemiology of esophageal squamous cell carcinoma. Abnet CC, Arnold M, Wei WQ. Gastroenterology. 2018;154:360–373. - PMC - PubMed
    1. Pathology of esophageal cancer and Barrett's esophagus. Jain S, Dhingra S. Ann Cardiothorac Surg. 2017;6:99–109. - PMC - PubMed

Publication types

LinkOut - more resources